What Covid-19 tells us about the pharma industry

Switzerland is the home of some of the world’s biggest pharmaceutical companies. But when it comes to coronavirus vaccines, the Swiss pharma giants are not part of the discussion.

This content was published on April 13, 2021 - 10:00

In this episode of The Swiss Connection podcast, host Susan Misicka talks to journalist Jessica Davis Plüss, who covers multinational corporations. How did the Swiss pharma firms miss out? Or did they? And what does it mean for the next pandemic?

External Content

For more Swiss stories for the world, subscribe to The Swiss Connection wherever you get your podcasts – such as Apple PodcastsExternal link, PlayerFMExternal link or SpotifyExternal link.

External Content

Got an idea for an episode? Let us know in the comments below. We’d love to hear from you!

Comments under this article have been turned off. You can find an overview of ongoing debates with our journalists here. Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at

Share this story

Join the conversation!

With a SWI account, you have the opportunity to contribute on our website.

You can Login or register here.